Radiotherapy & Oncology
Volume 95, Issue 3 , Pages 292-297 , June 2010

Multicentre phase I–II trial of capecitabine and oxaliplatin in combination with radiotherapy for unresectable pancreatic and biliary tract cancer: The CORGI-U study

  • Adalsteinn Gunnlaugsson

      Affiliations

    • Department of Oncology; and
    • Corresponding Author InformationCorresponding author. Address: Department of Oncology, Lund University Hospital, Lund 22185, Sweden.
    • ,
  • Harald Anderson

      Affiliations

    • Department of Cancer Epidemiology, Lund University, Sweden
    • ,
  • Pehr Lind

      Affiliations

    • Departments of Oncology and Pathology, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden
    • ,
  • Bengt Glimelius

      Affiliations

    • Departments of Oncology and Pathology, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden
    • Departments of Oncology, Radiology and Clinical Immunology, Akademiska Hospital, Uppsala University, Sweden
    • ,
  • Anders Johnsson

      Affiliations

    • Department of Oncology; and

Received 23 November 2009 ,Revised 10 March 2010 ,Accepted 5 April 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0167-8140(10)00230-6

doi: 10.1016/j.radonc.2010.04.004

Radiotherapy & Oncology
Volume 95, Issue 3 , Pages 292-297 , June 2010

Article Tools

* Image Usage & Resolution